Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
The National Institutes of Health and the Bill & Melinda Gates Foundation are committing $100 million each to develop affordable gene therapies for HIV and sickle cell disease. Sickle cell could be cured with gene-replacement or gene-editing approaches, and preclinical research indicates that CRISPR gene editing could chop up HIV genomes hiding in the body. Both programs will focus on in vivo therapies, in which cells are altered inside the body. The biggest challenge for both could be lowering manufacturing costs.
This article has been sent to the following recipient: